Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
01 14ATHENA
02 6LUPIN
03 8SALIX
01 27569612
02 27658944
03 27741373
04 47741374
05 67915247
06 48026281
07 28124125
08 28481078
09 29173847
10 29314447
01 28Blank
01 10Y
02 18Blank
01 62024-10-01
02 22024-12-09
03 42025-04-22
04 142027-08-20
05 22033-05-31
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Patent Expiration Date : 2027-08-20
US Patent Number : 7569612
Drug Substance Claim :
Drug Product Claim :
Application Number : 22418
Patent Use Code : U-1000
Delist Requested :
Patent Use Description : ADJUNCTIVE THERAPY TO ...
Patent Expiration Date : 2027-08-20
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Patent Expiration Date : 2027-08-20
US Patent Number : 7741374
Drug Substance Claim :
Drug Product Claim :
Application Number : 22418
Patent Use Code : U-1061
Delist Requested :
Patent Use Description : ADJUNCTIVE THERAPY TO ...
Patent Expiration Date : 2027-08-20
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Patent Expiration Date : 2027-08-20
US Patent Number : 7741373
Drug Substance Claim :
Drug Product Claim :
Application Number : 22418
Patent Use Code : U-1059
Delist Requested :
Patent Use Description : ADJUNCTIVE THERAPY TO ...
Patent Expiration Date : 2027-08-20
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Patent Expiration Date : 2027-08-20
US Patent Number : 7741374
Drug Substance Claim :
Drug Product Claim :
Application Number : 22418
Patent Use Code : U-1061
Delist Requested :
Patent Use Description : ADJUNCTIVE THERAPY TO ...
Patent Expiration Date : 2027-08-20
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Patent Expiration Date : 2027-08-20
US Patent Number : 7915247
Drug Substance Claim :
Drug Product Claim :
Application Number : 22418
Patent Use Code : U-1000
Delist Requested :
Patent Use Description : ADJUNCTIVE THERAPY TO ...
Patent Expiration Date : 2027-08-20